ArticleJournal of inflammation research2025
Integrated Single-Cell and Transcriptome Analysis with Experimental Validation Reveals PANoptosis-Related Gene Signatures in the Immune Microenvironment of Autoimmune Thyroiditis.
Article in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- PANoptosis in diabetes: immunometabolic insights and treatments.Apoptosis : an international journal on programmed cell death · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Autoimmune thyroiditis (AIT) is the most common organ-specific autoimmune disease, and its pathogenesis is closely related to the inflammatory microenvironment driven by immune cell penetration. The role of the newly proposed concept of PANoptosis in immune-related diseases is gradually being revealed. However, there is currently a lack of reports on PANoptosis in AIT. This study aims to clarify the relationship between PANoptosis gene, cell subgroup distribution, immune penetration, and AIT through a comprehensive analysis of scRNA-seq and bulk RNA-seq data combined with animal and clinical validation. Patients and Methods: Initially, we integrated bulk RNA-seq and scRNA-seq data from AIT in public databases to identify immune cell subpopulations and the distribution and abundance of PANoptosis within them. Subsequently, we applied ssGSEA to assess the association between immune cell infiltration and inflammatory responses in AIT patients versus healthy individuals. Furthermore, we utilized the WGCNA tool to integrate PANoptosis genes with immune functions and screened for gene modules most significantly correlated with the immune-inflammatory effects of AIT. Finally, an animal model was established and clinical samples were collected for RT-qPCR, immunohistochemical staining,Enzyme-linked immunosorbent assay (ELISA) and ROC curve to predict the diagnostic value for further verification. Results: Through bioinformatics analysis, we identified 14 functionally heterogeneous cell subpopulations and 5 differentially expressed PANoptosis-related genes (AIM2, ZBP1, NLRP6, MLKL, and FAS). Experimental validation revealed that these differentially expressed genes were significantly upregulated in autoimmune thyroiditis (AIT). Moreover, they might promote the infiltration of inflammatory lymphocytes and the secretion of inflammatory cytokines in thyroid tissue through the PANoptosis pathway, with AIM2 potentially playing a central role. Conclusion: In summary, our study reveals the characteristics of the immune microenvironment of AIT and highlights the clinical potential of PANoptosis-Related genes (AIM2, ZBP1, NLRP6, MLKL, and FAS) as diagnostic biomarkers.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.